Rami Imam1, Qing Chang1, Margaret Black1, Caroline Yu1, Wenqing Cao2. 1. Department of Pathology, New York University Grossman School of Medicine, 560 1st Ave, Tisch 4-15I, New York, NY, 10016, USA. 2. Department of Pathology, New York University Grossman School of Medicine, 560 1st Ave, Tisch 4-15I, New York, NY, 10016, USA. wenqing.cao@nyulangone.org.
Abstract
BACKGROUND: Recent studies have suggested the important roles of CD47 and tumor-associated macrophages in the prognosis and immunotherapy of various human malignancies. However, the clinical significance of CD47 expression and CD163+ TAMs in pancreatic neuroendocrine tumor (PanNET) remains unclear. METHODS: In this study, 47 well-differentiated PanNET resection specimens were collected. CD47 expression and CD163+ macrophages were evaluated using immunohistochemistry and correlated with clinicopathologic properties. RESULTS: Positive CD47 staining was seen in all PanNETs as well as adjacent normal islets. Compared to normal islets, CD47 overexpressed in PanNETs (p = 0.0015). In the cohort, lymph node metastasis (LNM), lymphovascular invasion (LVI), and perineural invasion (PNI) were found in 36.2, 59.6, and 48.9% of the cases, respectively. Interestingly, PanNETs with LNM, LVI, or PNI had significantly lower H-score of CD47 than those without LNM (p = 0.035), LVI (p = 0.0005), or PNI (p = 0.0035). PanNETs in patients with disease progression (recurrence/death) also showed a significantly lower expression of CD47 than those without progression (p = 0.022). In contrast, CD163+ macrophage counts were significantly higher in cases with LNM, LVI, and PNI. CONCLUSIONS: Our data suggest relative low CD47 expression and high CD163+ TAMs may act as indicators for poor prognosis of PanNETs.
BACKGROUND: Recent studies have suggested the important roles of CD47 and tumor-associated macrophages in the prognosis and immunotherapy of various humanmalignancies. However, the clinical significance of CD47 expression and CD163+ TAMs in pancreatic neuroendocrine tumor (PanNET) remains unclear. METHODS: In this study, 47 well-differentiated PanNET resection specimens were collected. CD47 expression and CD163+ macrophages were evaluated using immunohistochemistry and correlated with clinicopathologic properties. RESULTS: Positive CD47 staining was seen in all PanNETs as well as adjacent normal islets. Compared to normal islets, CD47 overexpressed in PanNETs (p = 0.0015). In the cohort, lymph node metastasis (LNM), lymphovascular invasion (LVI), and perineural invasion (PNI) were found in 36.2, 59.6, and 48.9% of the cases, respectively. Interestingly, PanNETs with LNM, LVI, or PNI had significantly lower H-score of CD47 than those without LNM (p = 0.035), LVI (p = 0.0005), or PNI (p = 0.0035). PanNETs in patients with disease progression (recurrence/death) also showed a significantly lower expression of CD47 than those without progression (p = 0.022). In contrast, CD163+ macrophage counts were significantly higher in cases with LNM, LVI, and PNI. CONCLUSIONS: Our data suggest relative low CD47 expression and high CD163+ TAMs may act as indicators for poor prognosis of PanNETs.
Authors: Alex D Michaels; Timothy E Newhook; Sara J Adair; Sho Morioka; Bernadette J Goudreau; Sarbajeet Nagdas; Matthew G Mullen; Jesse B Persily; Timothy N J Bullock; Craig L Slingluff; Kodi S Ravichandran; J Thomas Parsons; Todd W Bauer Journal: Clin Cancer Res Date: 2017-12-29 Impact factor: 12.531
Authors: Diane Tseng; Jens-Peter Volkmer; Stephen B Willingham; Humberto Contreras-Trujillo; John W Fathman; Nathaniel B Fernhoff; Jun Seita; Matthew A Inlay; Kipp Weiskopf; Masanori Miyanishi; Irving L Weissman Journal: Proc Natl Acad Sci U S A Date: 2013-05-20 Impact factor: 11.205
Authors: Arvind Dasari; Chan Shen; Daniel Halperin; Bo Zhao; Shouhao Zhou; Ying Xu; Tina Shih; James C Yao Journal: JAMA Oncol Date: 2017-10-01 Impact factor: 31.777
Authors: Simcha Weissman; Jefferey Sebrow; Hector H Gonzalez; Michael J Weingarten; Samuel Rosenblatt; Tej I Mehta; Rishi Thaker; Michael Krzyzak; Saad Saleem Journal: Cureus Date: 2019-03-21
Authors: Jeffrey R Whiteaker; Rachel A Lundeen; Lei Zhao; Regine M Schoenherr; Aura Burian; Dongqing Huang; Ulianna Voytovich; Tao Wang; Jacob J Kennedy; Richard G Ivey; Chenwei Lin; Oscar D Murillo; Travis D Lorentzen; Mathangi Thiagarajan; Simona Colantonio; Tessa W Caceres; Rhonda R Roberts; Joseph G Knotts; Joshua J Reading; Jan A Kaczmarczyk; Christopher W Richardson; Sandra S Garcia-Buntley; William Bocik; Stephen M Hewitt; Karen E Murray; Nhan Do; Mary Brophy; Stephen W Wilz; Hongbo Yu; Samuel Ajjarapu; Emily Boja; Tara Hiltke; Henry Rodriguez; Amanda G Paulovich Journal: Front Immunol Date: 2021-11-11 Impact factor: 8.786